Stock HSM HELIUS MEDICAL TECHNOLOGIES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Helius Medical Technologies, Inc. Toronto S.E.

Equities

HSM

US42328V1089

Delayed Toronto S.E.
Other stock markets
 		5-day change 1st Jan Change
- CAD -.--% Intraday chart for Helius Medical Technologies, Inc. +4.21% -.--%
Apr. 24 Helius Medical Technologies, Inc. Expands Stroke Clinical Program with Participation of Shepherd Center CI
Apr. 03 Top Premarket Gainers MT

Evolution of the average Target Price on Helius Medical Technologies, Inc.

Price target over the last 5 years

History of analyst recommendation changes

2aa78ad552216955601.snA5YGHCLiNtEWpYEglptiLS82q8OynchB0B_NwxPOU.1B5-FBOdcVIfeQEvYmso6UCBmViISmO00HM3re1ceI_dB1AwGIAcTDtQGQ~d71f60f725fb441baf4fd0fbf1c38e46

Analyst Recommendations on Helius Medical Technologies, Inc.

Traders Await Fresh Cues After Powell's Rate-Cut Commentary, Stifling US Equity Futures Pre-Bell MT
Maxim Starts Helius Medical Technologies at Buy With $1 Price Target MT
Roth Capital Starts Helius Medical Technologies at Buy With $5 Price Target MT
Noble Capital Downgrades Helius Medical Technologies to Market Perform from Outperform MT
HELIUS MEDICAL TECHNOLOGIES : Noble Capital Starts Helius Medical Technologies at Outperform With $20 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
3.99 USD
Average target price
15.47 USD
Spread / Average Target
+287.64%
High Price Target
24 USD
Spread / Highest target
+501.50%
Low Price Target
7.4 USD
Spread / Lowest Target
+85.46%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Helius Medical Technologies, Inc.

Maxim
Roth Capital Partners
Noble Capital

Ratings for Helius Medical Technologies, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. HSDT Stock
  4. HSM Stock
  5. Consensus Helius Medical Technologies, Inc.